One income share I have been eyeing for a while as a possible addition to my portfolio has fallen 15% so far this year. That, combined with a dividend increase, means the FTSE 250 share now yields 8.2%.
Could now be the time to swoop while the share continues to trade at current levels (45% cheaper than it was five years ago)? Or might the falling share price and high yield be warning signals of a classic value trap?
Attractive but complicated business sector
The share in question is Assura (LSE: AGR). Although the property company is far from a household name, its buildings are used at least occasionally by a sizeable part of the population. It specialises in healthcare properties, such as GP practice buildings and ambulance depots.
I think this is potentially an attractive business area, but not necessarily a straightforward one.
On the plus side, demand for healthcare services is resilient and I reckon if anything it will only grow over time. Those services require buildings in many cases. A GP surgery is exactly the sort of tenant I would be happy to have if I was a commercial landlord. In many cases it will stay in situ for decades. Any tenant can fall behind on rent, but this seems less likely with a GP surgery than a fashionable new retailer that is growing quickly, for example.
But I also see some challenges here. Putting up buildings with a specific purpose in mind can mean they are more costly to convert for other uses if that happens at some point in future. Plus, healthcare is and is likely to remain a politically contentious topic. Making big profits from it could be a double-edged sword when it comes to corporate reputation and also the potential for future rent increases.
Debt-heavy Assura has its work cut out
Still, with net rental income of £143m last year, Assura has proven it can operate a sizeable property portfolio focused on the healthcare sector and collect sizeable rents.
But doing that has involved borrowing a lot of money. Assura ended last year with £1.2bn in net debt. That is not far short of its current market capitalisation of £1.3bn.
Here, the investment case moves more closely to that of any property company, in my view.
To expand, Assura has borrowed. Servicing that debt is burdensome. Given the poor track record of the income share when it comes to price, growing the dividend each year likely helps to sustain some investor enthusiasm.
But dividends just add to the company’s need for cash. Indeed, last year, Assura spent £86m paying dividends. That represented a sizeable chunk of the £102m it generated in net cash inflow from operating activities. With £98m of net cash outflow from investing activities, the company saw more cash go out the door last year than come in.
Funding its balance sheet and the dividend (with or without growing it) will remain a challenge, in my view. Given the balance of risks and rewards, for now I will not be adding the income share to my portfolio.
The post Is this 8.2%-yielding income share a bargain or a value trap? appeared first on The Motley Fool UK.
Should you buy Assura Plc now?
Don’t make any big decisions yet.
Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.
And he believes they could bring spectacular returns over the next decade.
Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows…
When such enormous changes hit a big industry, informed investors can potentially get rich.
So, with his new report, Mark’s aiming to put more investors in this enviable position.
Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!
Grab your FREE Energy recommendation now
More reading
I’d buy this pair of high-yield FTSE 250 stocks to target £1,000 a year in passive income!
3 super-safe dividend shares I’d buy to target a £1,380 passive income!
C Ruane has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
